Strategy Planning

We met with one of our Advisory board members, Dr Sheuli Porkess, and her colleague Dr David Montgomery at our Medicity site yesterday. Sheuli and David have cofounded PM Life Sciences Sciences Consulting to help companies like ValiRx and Inaphaea commercialise their assets. Between them, David and Sheuli bring a wealth of big pharmaceutical experience (Boehringer Ingelheim, Pfizer and Ipsen) specifically leveraging their deep life science expertise to provide strategic insight and hands-on operational support to allow pharmaceutical companies to do things differently - smarter, faster and more efficiently. So as ValiRx enters this new chapter of commercialisation, their expertise is perfectly aligned to our mission and will bridge any gaps between our vision and real world implementation of our pipeline into the market - basically helping us get our innovative treatments into the market to reach patients who need them the most and deliver returns to those who have supported their development.